EP1212075A4 - Peptide die die funktion von cd66 familienmitgliedern modulieren können - Google Patents

Peptide die die funktion von cd66 familienmitgliedern modulieren können

Info

Publication number
EP1212075A4
EP1212075A4 EP00957846A EP00957846A EP1212075A4 EP 1212075 A4 EP1212075 A4 EP 1212075A4 EP 00957846 A EP00957846 A EP 00957846A EP 00957846 A EP00957846 A EP 00957846A EP 1212075 A4 EP1212075 A4 EP 1212075A4
Authority
EP
European Patent Office
Prior art keywords
ceacam
modulating
function
family members
peptides capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00957846A
Other languages
English (en)
French (fr)
Other versions
EP1212075A1 (de
Inventor
Keith M Skubitz
Amy P N Skubitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1212075A1 publication Critical patent/EP1212075A1/de
Publication of EP1212075A4 publication Critical patent/EP1212075A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00957846A 1999-08-26 2000-08-25 Peptide die die funktion von cd66 familienmitgliedern modulieren können Withdrawn EP1212075A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15079199P 1999-08-26 1999-08-26
US150791P 1999-08-26
US15250199P 1999-09-02 1999-09-02
US152501P 1999-09-02
PCT/US2000/023482 WO2001013937A1 (en) 1999-08-26 2000-08-25 Peptides capable of modulating the function of cd66 (ceacam) family members

Publications (2)

Publication Number Publication Date
EP1212075A1 EP1212075A1 (de) 2002-06-12
EP1212075A4 true EP1212075A4 (de) 2005-11-23

Family

ID=26848045

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00957846A Withdrawn EP1212075A4 (de) 1999-08-26 2000-08-25 Peptide die die funktion von cd66 familienmitgliedern modulieren können

Country Status (4)

Country Link
EP (1) EP1212075A4 (de)
AU (1) AU6940700A (de)
CA (1) CA2383562A1 (de)
WO (1) WO2001013937A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298248T1 (de) 1998-04-15 2005-07-15 Brigham & Womens Hospital T-zell inhibierende rezeptorzusammensetzungen sowie deren verwendung
SE0002835D0 (sv) * 2000-08-07 2000-08-07 Karolinska Innovations Ab Method and kit for production of monoclonal antibodies
US20040214184A1 (en) * 2001-02-28 2004-10-28 Skubitz Keith M Small peptides capable of modulating the function of cd66 (ceacam) family members
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
EP1898942B1 (de) * 2004-07-14 2012-09-05 Biospectrum, Inc. Antiproliferative peptide
WO2007063424A2 (en) 2005-06-09 2007-06-07 Gal Markel The modulation of immunity and ceacam1 activity
EP1780220A1 (de) 2005-11-01 2007-05-02 Charité - Universitätsmedizin Berlin Gebrauch der CEACAM8-spezifischen Substanzen für das Behandeln von Autoimmunkrankheiten und ein Verfahren zur Auswahl von Substanzen, die Apoptosis verursachen
EP1988901B1 (de) * 2006-02-27 2020-01-29 Gal Markel Antibakterielle wirkstoffe auf caecam-basis
EP2377883A1 (de) 2010-04-15 2011-10-19 Universite d'Auvergne Clermont I Antagonisten zur Vorbeugung oder Behandlung von entzündlicher Darmerkrankung, speziell von Morbus Crohn
WO2013054320A1 (en) 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
CN104937100B (zh) * 2012-12-25 2020-04-03 宝生物工程株式会社 Aav 变体
US11427647B2 (en) 2014-04-27 2022-08-30 Famewave Ltd. Polynucleotides encoding humanized antibodies against CEACAM1
EA037613B1 (ru) 2014-04-27 2021-04-21 Фэймуэйв Лтд. Гуманизированные антитела против ceacam1
TWI565712B (zh) 2014-10-20 2017-01-11 福又達生物科技股份有限公司 增進神經元生長的胜肽及其應用
CR20190508A (es) * 2017-04-10 2020-01-08 Immatics Biotechnologies Gmbh Péptidos y combinaciones de los mismos para el uso en la inmunoterapia contra diversos tipos de cáncer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0445788A (ja) * 1990-06-08 1992-02-14 Suntory Ltd 癌胎児性抗原関連蛋白質
WO1995006067A1 (en) * 1993-08-21 1995-03-02 Imperial Cancer Research Technology Limited Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
WO1995032286A2 (en) * 1994-05-20 1995-11-30 Microgenesys, Inc. Immunogenic carcinoembryonic antigen and methods of use and production
WO1999041370A1 (en) * 1998-02-12 1999-08-19 Mcgill University Cea/nca-based differentiation cancer therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0445788A (ja) * 1990-06-08 1992-02-14 Suntory Ltd 癌胎児性抗原関連蛋白質
WO1995006067A1 (en) * 1993-08-21 1995-03-02 Imperial Cancer Research Technology Limited Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
WO1995032286A2 (en) * 1994-05-20 1995-11-30 Microgenesys, Inc. Immunogenic carcinoembryonic antigen and methods of use and production
WO1999041370A1 (en) * 1998-02-12 1999-08-19 Mcgill University Cea/nca-based differentiation cancer therapy

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 23 July 1992 (1992-07-23), "Carcino embryonic antigen-related antigen encoded by clone W211.", XP002333992, retrieved from EBI accession no. GSN:AAR22044 Database accession no. AAR22044 *
KUIJPERS T W ET AL: "CD66 NONSPECIFIC CROSS-REACTING ANTIGENS ARE INVOLVED IN NEUTROPHIL ADHERENCE TO CYTOKINE-ACTIVATED ENDOTHELIAL CELLS", JOURNAL OF CELL BIOLOGY, vol. 118, no. 2, 1992, pages 457 - 466, XP002313088, ISSN: 0021-9525 *
KUROKI M ET AL: "Molecular cloning of nonspecific cross-reacting antigens in human granulocytes.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 25 JUN 1991, vol. 266, no. 18, 25 June 1991 (1991-06-25), pages 11810 - 11817, XP002313086, ISSN: 0021-9258 *
LUO W ET AL: "Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains.", ONCOGENE. 10 APR 1997, vol. 14, no. 14, 10 April 1997 (1997-04-10), pages 1697 - 1704, XP002313089, ISSN: 0950-9232 *
See also references of WO0113937A1 *
SKUBITZ KEITH M ET AL: "CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 60, no. 1, 1996, pages 106 - 117, XP009042382, ISSN: 0741-5400 *
STOCKS S CRAIG ET AL: "CD66: Role in the regulation of neutrophil effector function", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 26, no. 12, 1996, pages 2924 - 2932, XP009049851, ISSN: 0014-2980 *
ZHOU HUA ET AL: "Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds", JOURNAL OF CELL BIOLOGY, vol. 122, no. 4, 1993, pages 951 - 960, XP002313087, ISSN: 0021-9525 *

Also Published As

Publication number Publication date
WO2001013937A9 (en) 2002-09-06
AU6940700A (en) 2001-03-19
WO2001013937A1 (en) 2001-03-01
EP1212075A1 (de) 2002-06-12
CA2383562A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
EP1472276A4 (de) Kleine, zur modulation der funktion von mitgliedern der cd66 (ceacam)-familie fähige peptide
EP1212075A4 (de) Peptide die die funktion von cd66 familienmitgliedern modulieren können
GB2348008B (en) Reconnaissance probe
EP1174482A4 (de) Dichtung
ZA989082B (en) Gasket
GB9715291D0 (en) Gasket
GB2328989B (en) Gaskets
GB9926537D0 (en) Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds
HK1031156A1 (en) Engagement device capable of readily integrating two members
IL122534A0 (en) Projector
NZ330840A (en) Cooking aid of the coarse-grained type
GB2325497B (en) Gaskets
GB2325496B (en) Gaskets
GB2327484B (en) Gasket
GB2326201B (en) Gaskets
CA87967S (en) Gasket
CA87329S (en) Gasket
CA87969S (en) Gasket
CA87965S (en) Gasket
CA87328S (en) Gasket
CA87330S (en) Gasket
GR2002185Y (en) Rusk of the peasant type
GB9816461D0 (en) Wheelie-bin bug killer
TW423777U (en) Modulator improvement of the detection system
PL335847A1 (en) Stuffing-box

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020326

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20051010

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061024